Fig. 1.
Expression and functionality of CXCR4 on BM myeloma cells.
(A) Myeloma CD38hiCD45RA− BM cells and myeloma-derived cell lines were incubated with the anti-CXCR4 44.717.111 or control [C] P3X63 mAb and analyzed by flow cytometry. Results from 3 different CD38hiCD45RA− BM samples (upper panels) expressing low (left), medium (middle), or high (right) levels of CXCR4 is shown. (B) Myeloma CD38hiCD45RA− BM and NCI-H929 cells were preincubated without or with pertussis toxin (PTx) in DMEM/BSA 0.5% and allowed to migrate in Transwell chemotaxis chambers to medium alone or an SDF-1α–containing lower chamber. Results from 3 different MM-CD38hiCD45RA− BM samples expressing medium or high levels of CXCR4 are shown. Data represent the mean ± SD of duplicate samples. (C) Cells were incubated for the indicated times with SDF-1α (solid circles) or adhesion medium (open circles), stained with fluorescein isothiocyanate–phalloidin, and subjected to flow cytometry.